πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 80 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12370255

Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFERβ€”NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12370142

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12318483

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12304900

Islet cell manufacturing compositions and methods of use

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12296047

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12291058

Dispersions for additive manufacturing comprising discrete carbon nanotubes

MOLECULAR REBAR DESIGN, LLC Β· Granted Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12280149

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12251428

Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration o

China Medical University Β· Granted Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12251472

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12251468

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12246092

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12230379

Systems and methods for coordinating manufacturing of cells for patient-specific immunothe

Iovance Biotherapeutics, Inc. Β· Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12230378

Systems and methods for coordinating manufacturing of cells for patient-specific immunothe

Iovance Biotherapeutics, Inc. Β· Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12178909

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12170134

Systems and methods for coordinating manufacturing of cells for patient-specific immunothe

Iovance Biotherapeutics, Inc. Β· Granted Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12163153

Methods of manufacturing allogeneic CAR T cells

Allogene Therapeutics, Inc. Β· Granted Tue Dec 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12156940

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12159700

Systems and methods for coordinating manufacturing of cells for patient-specific immunothe

Iovance Biotherapeutics, Inc. Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12151024

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12150461

Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, an

Sovida Solutions Ltd. Β· Granted Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12144890

Manufacturing of bupivacaine multivesicular liposomes

Pacira Pharmaceuticals, Inc. Β· Granted Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11964003

Stable sustained release therapeutic compositions in aprotic polar solvents and methods of

XERIS PHARMACEUTICALS, INC. Β· Granted Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11957736

Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the

XERIS PHARMACEUTICALS, INC. Β· Granted Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11945795

Islet cell manufacturing compositions and methods of use

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted